Full View

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C Hostetter, LA Licata, CL Costantino… - Cancer biology & …, 2008 - Taylor & Francis
With prolonged exposure, a majority of estrogen receptor positive cancers develop
resistance to tamoxifen and subsequent therapies including selective estrogen receptor …
被引用次数：109 相关文章
[PDF] archive.org

[PDF][PDF] Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C Hostetter, LA Licata, A Witkiewicz… - Cancer Biology & …, 2008 - scholar.archive.org
De novo or acquired tamoxifen resistance is a significant clinical problem in the treatment of
breast cancer that occurs in at least 60% of cases and eliminates therapeutic effectiveness …

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C Hostetter, LA Licata… - Cancer Biology …, 2008 - utsouthwestern.elsevierpure.com
With prolonged exposure, a majority of estrogen receptor positive cancers develop
resistance to tamoxifen and subsequent therapies including selective estrogen receptor …

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells.

C Hostetter, LA Licata, A Witkiewicz… - Cancer Biology & …, 2008 - europepmc.org
With prolonged exposure, a majority of estrogen receptor positive cancers develop
resistance to tamoxifen and subsequent therapies including selective estrogen receptor …

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C Hostetter, LA Licata, A Witkiewicz… - Cancer biology & …, 2008 - pubmed.ncbi.nlm.nih.gov
With prolonged exposure, a majority of estrogen receptor positive cancers develop
resistance to tamoxifen and subsequent therapies including selective estrogen receptor …

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C Hostetter, LA Licata, A Witkiewicz… - Cancer Biology and …, 2008 - ohsu.elsevierpure.com
With prolonged exposure, a majority of estrogen receptor positive cancers develop
resistance to tamoxifen and subsequent therapies including selective estrogen receptor …

[引用][C] Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C Hostetter, LA Licata, CL Costantino… - Cancer Biology & …, 2008 - cir.nii.ac.jp
Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance
in estrogen receptor positive breast cancer cells | CiNii Research CiNii 国立情報学研究所 学術 …

[引用][C] Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C HOSTETTER - Cancer Biol. Ther., 2008 - cir.nii.ac.jp
Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen
resistance in estrogen receptor positive breast cancer cells | CiNii Research CiNii 国立 …

Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

C Hostetter, LA Licata… - Cancer Biology …, 2008 - utsouthwestern.elsevierpure.com
With prolonged exposure, a majority of estrogen receptor positive cancers develop
resistance to tamoxifen and subsequent therapies including selective estrogen receptor …